An HIV-positive man with tattoo induration

Clinical Infectious Diseases

Volumn 45, Issue 2, 2007, Pages

  López Medrano, Francisco ^a   Costa, José Ramón ^a   Rodríguez Peralto, José Luis ^a   Aguado, José María ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CD4 ANTIGEN; LAMIVUDINE; MEGLUMINE ANTIMONATE; NELFINAVIR; PENTAMIDINE; STAVUDINE; AMPHOTERICIN B; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RELAPSE; SKIN BIOPSY; SKIN INFILTRATE; TATTOO; TREATMENT RESPONSE; VIRUS LOAD; VISCERAL LEISHMANIASIS; AIDS RELATED COMPLEX; ANIMAL; DRUG COMBINATION; FOLLOW UP; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEEDLE BIOPSY; RECURRENT DISEASE; RISK ASSESSMENT; SKIN LEISHMANIASIS; TATTOOING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; IMMUNOHISTOCHEMISTRY; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PENTAMIDINE; RECURRENCE; RISK ASSESSMENT; TATTOOING;

EID: 34447106177     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518876     Document Type: Article

References (11)

1. Herwaldt BL. Leishmaniasis. Lancet 1999; 354:1191-9.
2. Berenguer J, Moreno S, Cercenado E, Bernaldo de Quiros JC, Garcia de la Fuente A, Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1989; 111:129-32.
3. Castellano VM, Rodriguez-Peralto JL, Alonso S, Gomez-De la Fuente E, Ibarrola C. Dermatofibroma parasitized by Leishmania in HIV infection: a new morphologic expression of dermal Kala Azar in an immunodepressed patient. J Cutan Pathol 1999; 26:516-9.
4. Colebunders R, Depraetere K, Verstraeten T, et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 1999; 41:847-50.
5. Elamin EM, Guerbouj S, Musa AM, et al. Uncommon clinical presentations of cutaneous leishmaniasis in Sudan. Trans R Soc Trop Med Hyg 2005; 99:803-8.
6. Abajo P, Buezo GF, Fraga J, Sanz J, Dauden E. Leishmaniasis and Kaposi's sarcoma in an HIV-infected patient. Am J Dermatopathol 1997; 19:101-3.
7. Gallego MA, Aguilar A, Plaza S, et al. Kaposi's sarcoma with an intense parasitization by Leishmania. Cutis 1996; 57:103-5.
8. Taillan B, Marty P, Schneider S, et al. Visceral leishmaniasis involving a cutaneous Kaposi's sarcoma lesion and free areas of skin. Eur J Med 1992; 1:255.
9. Romeu J, Milla F, Batlle M, et al. Visceral leishmaniasis involving lung and a cutaneous Kaposi's sarcoma lesion. AIDS 1991; 5:1272.
10. Visceral leishmaniasis. In: Despommier DD, Gwadz RW, Hotez PJ, Knirsch CA, eds. Parasitic diseases. 5th ed. New York: Apple Trees Productions, 2005:27-31.
11. Cutaneous deposits. In: Weedon D, Strutton G, eds. Skin pathology. 2nd ed. London: Churchill Livingstone, 2002:423-53.